Intrauterine infections and birth defects

Biomedical and Environmental Sciences

Volumn 17, Issue 4, 2004, Pages 476-491

  Zheng, Xiao Ying ^d   Zhang, Ting ^a,e   Wang, Yi Fei ^b   Xu, Chen ^c   Chen, Gong ^f   Xin, Ruo Lei ^a   Chen, Jia Peng ^f   Hu, Xu Mei ^b   Yang, Qing ^c   Song, Xin Ming ^f   Pang, Li Hua ^f   Ji, Ying ^f   Sun, Hong Mei ^a   Zhang, Lei ^f   Liu, Ju Fen ^f   Guo, Yan Ling ^f   Zhang, Yan ^f  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Institute of Population Research   (China)

^e Capital Children Hospital   (China)

^f NONE

Author keywords

Birth defects; Intrauterine infections; Rubella virus; Toxoplasma; Ureaplasma urealyticum

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CYTOKINE; CYTOMEGALOVIRUS VACCINE; DOXYCYCLINE; ENZYME; ERYTHROMYCIN; FOSCARNET; GANCICLOVIR; LEVOFLOXACIN; MACROLIDE; MEASLES MUMPS RUBELLA VACCINE; MINOCYCLINE; NORFLOXACIN; PROTOZOAL VACCINE; PYRIMETHAMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RUBELLA VACCINE; SPIRAMYCIN; SULFAPYRIDINE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ABORTION; AUTISM; BIRTH DEFECT; CHEMICAL TERATOGENESIS; CONDOM; CONGENITAL CATARACT; CONGENITAL RUBELLA SYNDROME; CONGENITAL TOXOPLASMOSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EARLY DIAGNOSIS; FEMALE STERILITY; FETUS DEATH; FETUS DEVELOPMENT; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GRAM NEGATIVE INFECTION; HEARING IMPAIRMENT; HEARING LOSS; HEPATITIS B VIRUS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; INTRAUTERINE GROWTH RETARDATION; INTRAUTERINE INFECTION; LOW BIRTH WEIGHT; MICROENVIRONMENT; PARVOVIRUS; PATHOGENESIS; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLACENTA; PLACENTAL TRANSFER; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PSYCHOSIS; REINFECTION; REVIEW; RUBELLA; RUBELLA VIRUS; SAFE SEX; SCHIZOPHRENIA; SEXUALLY TRANSMITTED DISEASE; STILLBIRTH; THROMBOCYTOPENIA; TOXOPLASMA; UREAPLASMA UREALYTICUM; UROGENITAL TRACT INFECTION; VERTICAL TRANSMISSION; VISUAL IMPAIRMENT;

ABNORMALITIES; ANIMALS; FEMALE; HUMANS; INFANT, NEWBORN; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; RUBELLA; TOXOPLASMA; UREAPLASMA UREALYTICUM;

CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; NEGIBACTERIA; PARVOVIRUS; RUBELLA VIRUS; SIMPLEXVIRUS; TOXOPLASMA; UREAPLASMA; UREAPLASMA UREALYTICUM;

EID: 19944432877     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Ushida, M., Katow, S., and Furukawa, S. (2003). Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine. Jpn. J. Infect. Dis. 56(2), 68-69.
2. Aboudy, Y., Barnea, B., Yosef, L., Frank, T., and Mendelson, E. (2000). Clinical rubella reinfection during pregnancy in a previously vaccinated woman. J. Infect. 41(2), 187-189.
3. Lamy, M. E., Mulongo, K. N., Gadisseux, J. E., Lyon, G., Gaudy, V., and Van, L. M. (1992). Prenatal diagnosis of fetal cytomegalovirus infection. Am. J. Obstet. Gynecol. 166(1 pt1), 91-94.
4. Barbi, M., Binda, S., Caroppo, S., Ambrosetti, U., Corbetta, C., and Sergi, P. (2003). A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr. Infect Dis. J. 22(1), 39-42.
5. Wilkinson, D., Barton, S., and Cowan, F. (2000). HSV-2 specific serology should be offered routinely to antenatal patients. Rev. Med. Virol. 10(3), 145-153.
6. Bosma, T. J., Corbett, K. M., Eckstein, M. B., O'Shea, S., Vijayalakshmi, P., Banatvala, J. E., Morton, K., and Best, J. M. (1995). Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J. Clin. Microbiol. 33(11), 2881-2887.
7. Noyola, D. E. and Mejía, Elizondo, A. R. (2003). Congenital cytomegalovirus infection in San Luis Potosi, Mexico. The Pediatric Infect Dis. J. 22(1), 89-90.
8. Fowler, K. B., Stagno, S., and Pass, R. F. (1993). Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations 1980-1990. J. Infect Dis. 168(3), 552-556.
9. Gabrielli, L., Lazzarotto, T., Foschini, M. P., Lanari, M., Guerra, B., Eusebi, V. and Landini, M. P. (2003). Horizontal in utero acquisition of cytomegalovirus infection in a twin pregnancy. J. Clin. Microbiol. 41(3), 1329-1331.
10. Numazaki, K. and Fujikawa, T. (2003). Intracranial calcification with congenital rubella syndrome in a mother with serologic immunity. J. Child Neurol. 18(4), 296-297.
11. Ziebold, C., Hassenpflug, B., Wegner-Brose, H., Wegner, K., and Schmitt, H. J. (2003). An outbreak of rubella aboard a ship of the German Navy. Infection 31(3), 136-142.
12. Forrest, J. M., Turnbull, F. M., Sholler, G. F., Hawker, R. E., Martin, F. J., Doran, T. T., and Burgess, M. A. (2002). Gregg's congenital rubella patients 60 years later. Med. J. Aust. 177(11-12), 664-667.
13. Fukuda, R., Sasaki, T., Kunugi, H., and Nanko, S. (1999). No changes in paired viral antibody titers during the course of acute schizophrenia. Neuropsychobiology 40(2), 57-62.
14. Williamson, W. D., Demmler, G. J., Percy, A. K., and Catlin, F. I. (1992). Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 90(6), 862-866.
15. Dahle, A. J., Fowler, K. B., Wright, J. D., Boppana, S. B., Britt, W. J., and Pass, R. F. (2000). Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11(5), 283-290.
16. Harrison, C. J. and Myers, M. G. (1990). Relation of maternal CMV viremia and antibody response to the rate of congenital infection and intrauterine growth retardation. J. Med. Virol. 31(3), 222-228.
17. Revello, M. G., Zavattoni, M., Furione, M., Lilleri, D., Gorini, G., and Gerna, G. (2002). Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J. Infect Dis. 186(4), 553-557.
18. Lee, J. Y. and Bowden, D. S. (2000). Rubella virus replication and links to teratogenicity. Clin. Microbiol. Rev. 13(4), 571-587.
19. Megyeri, K., Berencsi, K., Halazonetis, T. D., Prendergast, G. C., Gri, G., Plotkin, S. A., Rovera, G., and Gonczol, E. (1999). Involvement of a p53-dependent pathway in rubella virus-induced apoptosis. Virology 259(1), 74-84.
20. Atreya, C. D., Lee, N. S., Forng, R. Y., Hofmann, J., Washington, G., Marti, G., and Nakhasi, H. L. (1998). The rubella virus putative replicase interacts with the retinoblastoma tumor suppressor protein. Virus Genes 16(2), 177-183.
21. Brown, A. S. and Susser, E. S. (2002). In utero infection and adult schizophrenia. Ment Retard Dev. Disabil. Res. Rev. 8(1), 51-57.
22. Compton, T., Kurt-Jones, E. A., Boehme, K. W., Belko, J., Latz, E., Golenbock, D. T., and Finberg R. W. (2003). Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77(8), 4588-4596.
23. Xanthakos, S. A. and Schleiss, M. R. (2003). Glycoprotein B genotyping of cytomegalovirus strains isolated in a pediatric population. The pediatric infectious disease journal 22(5), 462-463.
24. Barbi, M., Binda, S., Caroppo, S., Primache, V., Dido, P., Guidotti, P., Corbetta, C., and Melotti, D. (2001). CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies. J. Clin. Virol. 21(1), 75-79.
25. Lukacsi, A., Tarodi, B., Endreffy, E., Babinszki, A., Pal, A., and Pusztai, R. (2001). Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary. J. Med. Virol. 65(3), 537-542.
26. Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., and Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med. 347(19), 1477-1482.
27. Spitzer, W. O. (2003). Measles, Mumps, rubella vaccination and autism. N. Engl. J. Med. 348(10), 951-954.
28. Lingam, R., Simmons, A., Andrews, N., Miller, E., Stowe, J., and Taylor, B. (2003). Prevalence of autism and parentally reported triggers in a north east London population. Arch. Dis. Child 88(8), 666-670.
29. Galazka, A. (1991). Rubella in Europe. Epidemiol. Infect 107(1), 43-54.
30. Pescovitz, M. D. (1999). Absence of teratogenicity of oral ganciclovir used during early pregnancy in a liver transplant recipient. Transplantation 67(5), 758-789.
31. Boppana, S. B., Rivera, L. B., Fowler, K. B., Mach, M., and Britt, W. J. (2001). Intrauterine Transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344(18), 1366-1371.
32. Fowler, K. B., Stagno, S., and Pass, R. F. (2003). Maternal immunity and prevention of congenital cytomegalovirus infection. J.A.M.A. 289(8), 1008-1011.
33. Temperton, N. J., Quenelle, D. C., Lawson, K. M., Zuckerman, J. N., Kern, E. R., Griffiths, P. D., and Emery, V. C. (2003). Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides. J. Med. Virol. 70(1), 86-90.
34. Griffiths, P. D. (2002). Strategies to prevent CMV infection in the neonate. Semin Neonatol. 7(4), 293-299.
35. Wang, E. E., Cassell, G. H., Sanchez, P. J., Regan, J. A., Payne, N. R., and Liu, P. P. (1993). Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation. Clin. Infect Dis. 17(Suppl. 1), S112-S116.
36. Sanchez, P. J. and Regan, J. A. (1990). Vertical transmission of Ureaplasma urealyticum from mothers to preterm infants. Pediatr. Infect Dis. J. 9(6), 398-401.
37. Abele-Horn, M., Peters, J., Genzel, Boroviczeny, O., Wolff, C., Zimmermann, A., and Gottschling, W. (1997). Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection 25(5), 286-291.
38. Syrogiannopoulos, G. A., Kapatais-zoumbos, K., Decavalas, G. O., Markantes, C. G., Katsarou, V. A., and Beratis N. G. (1990). Ureaplasma urealyticum colonization of full term infants: perinatal acquisition and persistence during early infancy. Pediatr. Infect Dis. J. 9(4), 236-240.
39. Gray, D. J., Robinson, H. B., Malone, J., and Thomson, R. B. (1992). Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 12(2), 111-117.
40. Neman-Simha, V., Renaudin, H., de Barbeyrac, B., Leng, J. J. Horovitz, J., Dallay, D., Billeaud, C., and Bebear, C. (1992). Isolation of genital mycoplasmas from blood of febrile obstetrical-gynecologic patients and neonates. Scand. J. Infect Dis. 24(3), 317-321.
41. Zhao, X. L., Shun, Y. P., Li, L. X., and Li Y. M. (2001). Discussion of the Vertical Mother-to-child Infection of Ureaplasma Urealyticum. Chinese Journal of Birth Health and Heredity 9(2), 67-89.
42. Donders, G. G., Van Bulck, B., Caudron, J., Londers, L., Vereecken, A., and Spitz, B. (2000). Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am. J. Obstet. Gynecol. 183(2), 431-437.
43. Gerber, S., Vial, Y., Hohlfeld, P., and Witkin, S. S. (2003). Detection of Ureaplasma urealyticum in second trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J. Infect Dis. 187(3), 518-521.
44. Hillier, S. L., Martius, J., Krohn, M., Kiviat, N., Holmes, K. K., and Eschenbach, D. A. (1988). A case control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N. Engl. J. Med. 319(15), 972-978.
45. Goncalves, L. F., Chaiworapongsa, T., and Romero, R. (2002). Intrauterine infection and prematurity. Ment. Retard Dev. Disabil. Res. Rev. 8(1), 3-13.
46. Steiner, D. A. and Brown, M. B. (1993). Impact of experimental genital mycoplasmosis on pregnancy outcome in Sprague-Dawley Rate. Infect Immun. 61(2), 633-639.
47. Sun, H. M., Guo, Z. G., Zhang, J. H., Shen, Y. L., Wang, L. H., and Zhao, X. Y. (1995). Placental ureaplasma urealyticum ifection and low birth weight. Chin. J. Obstet. Gynecol. 30(6), 340-341.
48. Yoon, B. H., Chang, J. W., and Romero, R. (1998). Isolation of Ureaplasma urealyticum from the amniotic cavity and adverse outcome in preterm labor. Obstet. Gynecol. 92(1), 77-82.
49. Germain, M., Krohn, M. A., Hillier, S. L., and Eschenbach, D. A. (1994). Genital flora in pregnancy and its association with intrauterine growth retardation. J. Clin. Microbiol. 32(9), 2162-2168.
50. Wang, X. P. (1998). Mycoplasma Infection and Pregnant Outcomes. Applied Gynaecology and Obstetrics Journal 14(1), 9-10.
51. Valencia, G. B., Banzon, F., Cummings, M., McCormack, W. M., Glass, L., and Hammerschlag, M. R. (1993). Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection. Pediatr. Infect Dis. J. 12(7), 571-573.
52. Quinn, P. A., Gillan, J. E., Markestad, T., John, M. A. St., Daneman, A., Lie, K. I., Li, H. C., Czegledy-Nagy, E., and Klein, A. (1985). Intrauterine infection with Ureaplasma urealyticum as a cause of fatal neonatal pneumonia. Pediatr. Infect Dis. 4(5), 538-543.
53. Cassel, G. H., Waites, K. B., Gibbs, R. S., and Davis, J. K. (1986). Role of ureaplasma urealyticum in amnionitis. Pediatr. Infect Dis. J. 5(Suppl.6), S247-52.
54. De Silva, N. S. and Quinn, P. A. (1991). Localization of endogenous activity of phospholipases A and C in ureaplasma urealyticum. J. Clin. Microbiol. 29(7), 1498-1501.
55. Zhou, L. P., Zhou, J., Bao, Q. Y., Fang, Z. X., Chen, S. H., Xie, A. L., Xu, X. W., and Wang, L. (1999). Ureaplasma Urealyticum Infection and Premature Delivery or Premature of the Membrane. Chin. J. Obstet. Gynecol. 34(5), 287-289.
56. Jacobsson, B., Mattsby, Baltzer, I., Andersch, B., Bokström, H, Holst, R-M, Wennerholm, U-Bt, and Hagberg, Henrik (2003). Microbial invasion and cytokine response in amniotic fluid in a Swedish population of women in preterm labor. Acta Obstet. Gynecol. Scand. 82(2), 120-128.
57. Zhao, S. X., Liu, J. Y., Hao, F. L., Wang, C. W., He, L. Y., Yang, T. S., Yang, Z. Y., He, P., and Li, Q. F. (1989). Survey and Research of the Relation between Toxoplasma Infection and Fetal Deformity and Stillbirth of the Early Pregnant Women in Beijing. Chinese Medicine Journal 69(1), 50-52.
58. Shi, J. L., Chen, P. Q., Zhang, R., and Lu, Y. N. (1992). Clinical Pathological Observation of Toxoplasma Infection and Fetal Congenital Nervous System Deformity. Applied Clinical Pediatrics Journal 7(2), 63-64.
59. Vallochi, A. L., Nakamura, M. V., Schlesinger, D., Martins, M. C., Silveira, C., Belfort, R. J., and Rizzo, L. V. (2002). Ocular toxoplasmosis: more than just what meets the eye. Scand. J. Immunol. 55(4), 324-328.
60. Huang, A. F. and Huang, K. Y. (1998). Discussion on Diagnosis and Treatment for the Mother-to-child Transmission of Infant Hepatitis Syndrome and Toxoplasma Infection. Chinese Journal of Zoonoses 14(6), 84.
61. Mcleod, R., Mack, D., and Brown, C. (1991). Toxoplasma gondii - new advances in cellular and molecular biology. Exp. Parasitol. 72(1), 109-121.
62. Saffer, L. D., Mercereau-Puijalon, O., Dubremetz, J. F., and Schwartzman, J. D. (1992). Localization of a Toxoplasma gondii rhoptry by immunoelection microscopy during and after host cell penetration. J. Protozool. 39(4), 526-530.
63. Saffer, L. D., Long, Krug, S. A., and Schwartzman, J. D. (1989). The role of phospholipase in host cell penetration by Toxoplasma gondii. Am. J. Prop. Med. Hyg. 40(2), 145-149.
64. Saffer, L. D. and Schwartzman, J. D. (1991). A soluble phospholipase of Toxoplasma gongdii associated with host cell penetration. J. Protozool. 38(5), 454-460.
65. Goyal, M., Ganguly, N. K., and Mahajan, R. C. (1988). Cytotoxic activity of monocytes against Toxoplasma gondii in acute, chronic toxoplasmosis. Med. Microbiol. Immunol. (Berl) 17, 339-348.
66. Langermans, J. A., Van der, Hulst, M. E., Nibbering, P. H., Hiemstra, P. S., Fransen, L., and Van Furth, R. (1992). IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J. Immunol. 148(2), 568-574.
67. Aliberti, J., Valenzuela, J. G., and Carruthers, V. B. (2003). Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nature Immunol. 4(5), 485-490.
68. Hofgartner, W. T., Swanzy, S. R., Bacina, R. M., Condon, J., Gupta, M., Matlock, P. E., Bergeron, D. L., Plorde, J. J., and Fritsche, T. R. (1997). Detection of Immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems. J. Clin. Microbio. 35(12), 3313-3315.
69. Naessens, A., Foulon, W., Breynaert, J., and Lauers, S. (1988). Serotypes of Ureaplasma urealyticum isolated from normal pregnant women and patients with pregnancy complications. J. Clin. Microbio. 26(2), 319-322.
70. Sun, H. M., Guo, Z. G., and Zhang, J. H. (1997). PCR types of Ureaplasma urealyticum in pregnancy women and the influence to newborns. Chin. J. Zoonoses 13(5), 251-252.
71. Baschat, A. A., Towbin, J., Bowles, N. E., Harman, C. R., and Weiner, C. P. (2003). Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J. Matern Fetal Neonatal Med. 13(6), 381-384.